Dr. Louis O'Dea joins Oxford Immunotec Global plc (OXFD -1.7%) as Chief Medical Officer. He will support the company's continued growth in its T-SPOT.TB business and the development of new products via his management of Oxford's medical education and clinical trial programs. He joins the company from Moderna Therapeutics where he had similar duties.
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs